An Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303
Clinical trial NCT03778424 · AVAILABLE
Trial details
- NCT number
- NCT03778424
- Sponsor
- Eisai Inc.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.